IRadimed Stock

IRadimed EBIT

The EBIT of IRadimed (IRMD) as of Aug 1, 2026 is 26.15 M USD. In the previous year, EBIT was 21.96 M USD — a change of 19.04% (higher).

EBIT

26.15 MUSD

YoY

19.04%

Last updated:

In 2026, IRadimed's EBIT was 26.15 M USD, a 19.04% increase from the 21.96 M USD EBIT recorded in the previous year.

The IRadimed EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (M USD)
Date
EBIT (M USD)
Jan 1, 2023
20.04 base
Jan 1, 2024
21.96 base
Jan 1, 2025
26.15 base
Jan 1, 2026 (e)
40.05 base
Jan 1, 2027 (e)
44.31 base
Jan 1, 2028 (e)
49.45 base
Jan 1, 2029 (e)
57.93 base
Jan 1, 2030 (e)
64.08 base
YEAREBIT (M USD)
2030 est 64.08
2029 est 57.93
2028 est 49.45
2027 est 44.31
2026 est 40.05
2025 26.15
2024 21.96
2023 20.04
2022 15.63
2021 9.82
2020 -0.76
2019 8.65
2018 6.00
2017 1.29
2016 10.92
2015 11.51
2014 3.07
2013 2.79
2012 1.42
Access this data via the Eulerpool API

IRadimed Revenue

IRadimed Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
65.56 M USD
20.04 M USD
17.19 M USD
Jan 1, 2024
73.24 M USD
21.96 M USD
19.23 M USD
Jan 1, 2025
83.81 M USD
26.15 M USD
22.48 M USD
Jan 1, 2026 (e)
91.20 M USD
40.05 M USD
26.67 M USD
Jan 1, 2027 (e)
100.90 M USD
44.31 M USD
30.27 M USD
Jan 1, 2028 (e)
112.60 M USD
49.45 M USD
34.71 M USD
Jan 1, 2029 (e)
131.90 M USD
57.93 M USD
39.08 M USD
Jan 1, 2030 (e)
145.90 M USD
64.08 M USD
44.09 M USD

IRadimed Margins

IRadimed stock margins

The IRadimed margin analysis displays the gross margin, EBIT margin, as well as the profit margin of IRadimed. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for IRadimed.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2023
76.50 %
30.56 %
26.22 %
Jan 1, 2024
76.94 %
29.99 %
26.26 %
Jan 1, 2025
76.75 %
31.20 %
26.82 %
Jan 1, 2026 (e)
76.75 %
43.92 %
29.25 %
Jan 1, 2027 (e)
76.75 %
43.92 %
30.00 %
Jan 1, 2028 (e)
76.75 %
43.92 %
30.82 %
Jan 1, 2029 (e)
76.75 %
43.92 %
29.63 %
Jan 1, 2030 (e)
76.75 %
43.92 %
30.22 %

IRadimed Stock analysis

What does IRadimed do? IRadimed Corp is an American company specializing in the development, manufacturing, and marketing of advanced medical technology products. The company was founded in 1992 and is headquartered in Winter Springs, Florida. It was founded to meet the need for advanced and precise medical devices used in intensive care. In recent years, the company has focused on the development of components and accessory products for magnetic resonance imaging (MRI) used in radiology and oncology. IRadimed Corp is known for its innovative and technologically advanced approach to the medical technology industry. The company prioritizes research and development and collaborates closely with clinics, hospitals, and medical facilities to provide the best solutions for patient care. It has a strong distribution network that allows its products to be distributed worldwide, particularly in the United States, Europe, and Asia. The company offers a wide range of medical devices and accessory products used in radiology, oncology, and other medical fields. Its specialty lies in manufacturing components and accessories for MRI. These include MRI-compatible infusion pumps, patient monitoring devices, ventilation devices, and coil arrays designed for imaging the skull and spine, as well as breast and prostate imaging. In summary, IRadimed Corp is a leading provider of medical devices and accessories for radiology, oncology, and other specialized fields. Its focus on MRI-compatible devices and accessories, as well as its collaborative approach with medical facilities, sets it apart in the industry. The company prides itself on innovation and technological advancement, offering a wide range of products tailored to the needs of patients and medical professionals. IRadimed is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing IRadimed's EBIT

IRadimed's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of IRadimed's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

IRadimed's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in IRadimed’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about IRadimed stock

EBIT of IRadimed is 26.15 M USD in 2026.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — IRadimed

All Key Metrics — IRadimed